Literature DB >> 10525998

Parkinsonism-dementia complex on Guam - overview of clinical aspects.

N Murakami1.   

Abstract

Parkinsonism-dementia complex (PDC) is the second most common neurodegenerative disorder in Guam, after amyotrophic lateral sclerosis (ALS). PDC was first described by Hirano 1961. A familial appearance is seen among some PDC cases, which may also include ALS, and vice versa, but subsequent research including pedigree analysis, prospective case control registries, and the search for specific gene markers has failed to yield a satisfactory genetic explanation. Important diagnostic indicators of the illness include rigido-akinetic type Parkinsonism and severe dementia.In PDC, rigidity is so marked that postural deformities such as a generally flexed posture become rather prominent. Gait disturbances are a common initial symptom. Hyperreflexia and spinal muscular atrophy, developing mainly in the distal extremities, are frequently observed. These mixed-syndrome patients can be seen as clear support for the view that Guam ALS and PDC constitute a single mixed disease entity with a spectrum of clinical expression. The present paper offers an overview and description of the clinical features of PDC.

Entities:  

Mesh:

Year:  1999        PMID: 10525998     DOI: 10.1007/bf03161077

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  5 in total

1.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features.

Authors:  A HIRANO; L T KURLAND; R S KROOTH; S LESSELL
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

2.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features.

Authors:  A HIRANO; N MALAMUD; L T KURLAND
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

3.  Neurologic diseases on the island of Guam.

Authors:  D W MULDER; L T KURLAND; L L IRIARTE
Journal:  U S Armed Forces Med J       Date:  1954-12

4.  Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations.

Authors:  L T KURLAND; D W MULDER
Journal:  Neurology       Date:  1954-05       Impact factor: 9.910

5.  Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation.

Authors:  T S Elizan; A Hirano; B M Abrams; R L Need; C Van Nuis; L T Kurland
Journal:  Arch Neurol       Date:  1966-04
  5 in total
  7 in total

1.  Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Authors:  Michael S Petrik; Margaret C Wong; Rena C Tabata; Robert F Garry; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

Authors:  Laura R Snyder; Reyniel Cruz-Aguado; Martin Sadilek; Douglas Galasko; Christopher A Shaw; Thomas J Montine
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

Review 3.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

4.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

Authors:  Mark S Forman; M Luise Schmidt; Sanjay Kasturi; Daniel P Perl; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

Authors:  M S Petrik; J M B Wilson; S C Grant; S J Blackband; R C Tabata; X Shan; C Krieger; C A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

6.  Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration.

Authors:  Christopher A Shaw; Michael S Petrik
Journal:  J Inorg Biochem       Date:  2009-08-20       Impact factor: 4.155

7.  Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.

Authors:  Bert M Verheijen; Kiyomitsu Oyanagi; Fred W van Leeuwen
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.